Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EGFR | P00533 | 6/20 | 0.44 |
| ▸ | LCK | P06239 | 3/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.39 |
| ▸ | MAPT | P10636 | 2/20 | 0.39 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | RGS12 | O14924 | 1/20 | 0.39 |
| ▸ | CAMKK2 | Q96RR4 | 1/20 | 0.39 |
| ▸ | NOX4 | Q9NPH5 | 1/20 | 0.39 |
| ▸ | HPGD | P15428 | 2/20 | 0.38 |
| ▸ | TP53 | P04637 | 1/20 | 0.38 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.38 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.38 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.38 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.38 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.38 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.38 |
| ▸ | CKS1B | P61024 | 1/20 | 0.38 |
| ▸ | SKP2 | Q13309 | 1/20 | 0.38 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.38 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3736876 | 0.98 | EGFR (0.43) | EGFRLCKALDH1A1MAPTTDP1 | |
| SCHEMBL2992940 | 0.87 | TYR (0.44) | ALDH1A1CA12CA1CA2ALOX5 | |
| SCHEMBL3742472 | 0.86 | TYR (0.43) | ALDH1A1CA12CA1CA2ALOX5 | |
| SCHEMBL3740588 | 0.86 | TYR (0.43) | ALDH1A1CA12CA1CA2ALOX5 | |
| SCHEMBL3734233 | 0.86 | TYR (0.43) | ALDH1A1CA12CA1CA2ALOX5 | |
| SCHEMBL3749332 | 0.86 | TYR (0.43) | ALDH1A1CA12CA1CA2ALOX5 | |
| SCHEMBL3746796 | 0.86 | TYR (0.43) | ALDH1A1CA12CA1CA2ALOX5 | |
| SCHEMBL2990736 | 0.86 | TYR (0.43) | ALDH1A1CA12CA1CA2ALOX5 | |
| Zinc Ion SCHEMBL3736872 | 0.84 | GABRA1 (0.37) | EGFRLCKALDH1A1MAPTTDP1 | |
| SCHEMBL3736826 | 0.79 | AKR1B1 (0.52) | ALDH1A1NOX4CYP1A2HIF1AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080287536-A1 | Skin and Hair Restoration by Natural Amino Acid and Peptide Crown Complexes | BIODERM RESEARCH (US) | 2008-11-20 | — | — | US | claimed |
| US-7834210-B2 | Hair loss prevention by natural amino acid and peptide complexes | BIODERM RESEARCH (US) | 2010-11-16 | — | — | US | disclosed |
| US-20090253668-A1 | Hair Loss Prevention by Natural Amino Acid and Peptide Complexes | BIODERM RESEARCH (US) | 2009-10-08 | — | — | US | disclosed |
| US-7572933-B2 | Skin and hair restoration by natural amino acid peptide complexes | BIODERM RESEARCH (US) | 2009-08-11 | — | — | US | disclosed |
| US-20080287536-A1 | Skin and Hair Restoration by Natural Amino Acid and Peptide Crown Complexes | BIODERM RESEARCH (US) | 2008-11-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080287536-A1 | Skin and Hair Restoration by Natural Amino Acid and Peptide Crown Complexes | MMP17, MC1R, TYR | EGFR 62/4885LCK 1023/4885ALDH1A1 3352/4885 |
| US-20090253668-A1 | Hair Loss Prevention by Natural Amino Acid and Peptide Complexes | MMP1, MMP17, MMP13 | EGFR 858/4885LCK 3931/4885ALDH1A1 1360/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.